Mainz Biomed is a diagnostics company for at home cancer detection
Investment in several rounds since 2020. Nasdaq IPO in 2021
Mainz Biomed is a diagnostics company for at home cancer detection
Investment in several rounds since 2020. Nasdaq IPO in 2021